Aspirin News and Research

RSS

Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.

Study reveals treatment and screening inequalities for patients with mental health problems

Patients with mental health problems may not be receiving the appropriate screening or treatments for illnesses including heart disease and stroke, a report from The University of Nottingham has shown.

7 Dec 2005

COX-2 inhibitors may not be as safe as originally thought

There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.

7 Dec 2005

Physicians slow to prescribe newer heart drugs

An analysis of the treatment received by more than 100,000 heart patients has shown that physicians' prescription practices for drugs proven effective for treating heart disease has shown steady improvement over the past three years, cardiologists at the Duke Clinical Research Institute (DCRI) have concluded.

7 Dec 2005

Low doses of aspirin increase chance of developing ulcers

Aspirin has long been hailed as one of the most effective, low-cost ways to help guard against a heart attack or stroke. However, international medical researchers caution that low doses of aspirin also increase a patient's chance of developing an ulcer, often without warning signs.

28 Nov 2005

48% of people with diabetes are not using aspirin to reduce risk of heart attack and stroke

Survey results released by the American College of Preventive Medicine (ACPM) found that nearly half (48%) of U.S. adults 40+ with diabetes are not utilizing aspirin therapy to reduce their risk of recurrent heart attack or stroke nor had they reported discussing such therapy with their healthcare provider.

26 Nov 2005

"Get With The Guidelines" programs improve care

After one year - Get With The GuidelinesSM programs used in hospitals significantly improved care for almost 30,000 coronary artery disease patients of all ages and sexes, according to research reported at the American Heart Association's Scientific Sessions 2005.

26 Nov 2005

Aspirin can significantly reduce the risk of stroke in women

A meta-analysis of more than 95,000 patients has shown that aspirin can significantly reduce the risk of stroke in women, but it appears to have no protective effect in men, according to a new analysis by Duke University Medical Center cardiologists.

21 Nov 2005

American physicians may be too liberal in their use of blood transfusions

In an analysis of some 24,000 patient records, the researchers found that Americans rushed to the hospital with heart attack symptoms have significantly higher rates of bleeding and transfusions after treatment than similar patients throughout the world.

21 Nov 2005

Aspirin advice ignored by those who need it

A daily dose of aspirin is an inexpensive, proven strategy for reducing the likelihood of heart disease among those most at risk for such disorders, yet a new study from the Stanford University School of Medicine shows that aspirin therapy is being used by fewer than one-third of the U.S. outpatients who would benefit from it.

20 Nov 2005

Lack of aggressive treatment for clogged leg blood vessels means missed heart attack prevention opportunity

Despite the fact that clogged arteries in the legs usually mean clogged arteries near the heart, doctors often fail to give heart-protecting drugs to people with severe leg blood vessel blockages, a new University of Michigan-led study finds.

15 Nov 2005

Taking either COX-2 inhibitors or NSAIDs after a heart attack increases the risk of death

In recent years, evidence has shown that patients treated with selective cyclo-oxygenase-2 (COX-2) inhibitors are at increased risk of heart attack and death. COX-2 inhibitors are used primarily to treat pain and arthritis in patients at risk of gastrointestinal bleeding.

13 Nov 2005

Zyflamend shows promise in the early treatment of prostate cancer

Data from the Columbia University Department of Urology demonstrates that Zyflamend, a unique herbal extract preparation, suppresses the growth of prostate cancer cells and induces prostate cancer cells to self-destruct via a process called "apoptosis."

13 Nov 2005

Non-steroidal anti-inflammatory drugs may prevent the development of oesophageal adenocarcinoma in patients with Barrett's oesophagus

Barrett’s oesophagus is a metaplastic disorder that develops in about 10% of people with chronic gastro-oesophageal reflux disease. Every year about 0.5%-1% of patients with Barrett’s oesophagus develop oesophageal adenocarcinoma.

10 Nov 2005

Use of traction to help treat low back pain has no benefit

"Traction was introduced before it was properly evaluated in high-quality randomized trials, and as an intervention is already part of usual practice,” said lead author Judy M.A. Clarke, M.D. “It is hard to convince health care providers not to use it."

10 Nov 2005

Aspirin and ibuprofen may significantly reduce the risk of esophageal cancer among people with Barrett's esophagus

Aspirin and other nonsteroidal anti- inflammatory drugs, such as ibuprofen, may significantly reduce the risk of esophageal cancer among people with Barrett's esophagus, a precancerous condition associated with chronic heartburn that affects an estimated 1 million to 2 million Americans.

8 Nov 2005

One in five Americans has or is at serious risk for developing diabetes

At least one in five Americans has or is at serious risk for developing diabetes, meaning millions are at an increased risk for cardiovascular disease, key health organizations are warning.

8 Nov 2005

Aspirin may prevent skin cancer

Australian scientists say that common drugs such as aspirin may hold the key to reducing the risk of developing skin cancer.

8 Nov 2005

Vaccine that targets nicotine rather than the brain's reaction to it

Since smoking became popular in America in the 1930s, lung cancer rates have continued to climb. Today, it is still the leading cause of cancer-related deaths, with totals more than the other five leading cancers combined.

3 Nov 2005

Ibuprofen and naproxen combined with aspirin increase risk of gastrointestinal complications

Patients who combine the common over-the counter pain medications ibuprofen and naproxen with aspirin have a risk of gastrointestinal complications including ulcers, perforations and bleeding that is two to three times greater than patients who take these medications but do not combine them with aspirin.

1 Nov 2005

Study demonstrates feasibility of a revolutionary, minimally invasive approach to introducing an electrical lead to stimulate the heart

Correcting the timing of heart contractions through cardiac resynchronization therapy can be a lifesaver for people with advanced heart failure. But the procedure, as it is done today, fails in about 15 percent of patients.

18 Oct 2005

Aspirin News and Research

Study reveals treatment and screening inequalities for patients with mental health problems

COX-2 inhibitors may not be as safe as originally thought

Physicians slow to prescribe newer heart drugs

Low doses of aspirin increase chance of developing ulcers

48% of people with diabetes are not using aspirin to reduce risk of heart attack and stroke

"Get With The Guidelines" programs improve care

Aspirin can significantly reduce the risk of stroke in women

American physicians may be too liberal in their use of blood transfusions

Aspirin advice ignored by those who need it

Lack of aggressive treatment for clogged leg blood vessels means missed heart attack prevention opportunity

Taking either COX-2 inhibitors or NSAIDs after a heart attack increases the risk of death

Zyflamend shows promise in the early treatment of prostate cancer

Non-steroidal anti-inflammatory drugs may prevent the development of oesophageal adenocarcinoma in patients with Barrett's oesophagus

Use of traction to help treat low back pain has no benefit

Aspirin and ibuprofen may significantly reduce the risk of esophageal cancer among people with Barrett's esophagus

One in five Americans has or is at serious risk for developing diabetes

Aspirin may prevent skin cancer

Vaccine that targets nicotine rather than the brain's reaction to it

Ibuprofen and naproxen combined with aspirin increase risk of gastrointestinal complications

Study demonstrates feasibility of a revolutionary, minimally invasive approach to introducing an electrical lead to stimulate the heart

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News